Patients with glaucoma who are using prostaglandin F (FP) receptor agonists to control their disease may experience ...

Our vision declines as we age leading to the development of various eye conditions such as presbyopia cataracts and glaucoma ...

Developments include low-dose atropine eye drops and LASIK procedures. The global myopia and presbyopia treatment market is projected to reach a value of $32.74b by 2030 at a compound annual growth ...

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, Paul Smith of Orasis Pharmaceuticals discusses the benefits that Qlosi provides patients with presbyopia. KOLOA ...

Presbyopia is caused by a stiffening in the lens of the eye that develops in people after the age of 40, and affects an estimated 128 million people in the US. AbbVie is recommending Vuity ...

In this Healio Video Perspective from Hawaiian Eye 2025, Jason Bacharach, MD, of North Bay Eye Associates, shares data on an aceclidine-based presbyopia-correcting eye drop from Lenz Therapeutics.

008). Topline data were announced from a phase 3 trial evaluating Brimochol TM preservative-free (PF), an investigational pupil-modulating therapeutic, in adults with presbyopia. Study ...

Further details will be presented at upcoming scientific meetings. "Tenpoint Therapeutics is the only company in the presbyopia category to demonstrate contribution of elements with BRIMOCHOL ...

The merger brings together a late-stage, potentially best-in-class, presbyopia-correcting eye drop, BRIMOCHOL™ PF, on track for NDA filing in 1H, 2025, with a promising pipeline of innovative ...